Cargando…
Index of the human papillomavirus (HPV) vaccine industry clinical study programmes and non-industry funded studies: a necessary basis to address reporting bias in a systematic review
BACKGROUND: Unabridged access to drug industry and regulatory trial registers and data reduces reporting bias in systematic reviews and may provide a complete index of a drug’s clinical study programme. Currently, there is no public index of the human papillomavirus (HPV) vaccine industry study prog...
Autores principales: | Jørgensen, Lars, Gøtzsche, Peter C., Jefferson, Tom |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774129/ https://www.ncbi.nlm.nih.gov/pubmed/29347995 http://dx.doi.org/10.1186/s13643-018-0675-z |
Ejemplares similares
-
Benefits and harms of the human papillomavirus (HPV) vaccines: systematic review with meta-analyses of trial data from clinical study reports
por: Jørgensen, Lars, et al.
Publicado: (2020) -
Benefits and harms of the human papillomavirus (HPV) vaccines: comparison of trial data from clinical study reports with corresponding trial register entries and journal publications
por: Jørgensen, Lars, et al.
Publicado: (2020) -
Risk of bias in industry-funded oseltamivir trials: comparison of core reports versus full clinical study reports
por: Jefferson, Tom, et al.
Publicado: (2014) -
Agnogenic practices: an analysis of UK gambling industry-funded youth education programmes
por: van Schalkwyk, MCI, et al.
Publicado: (2022) -
Distilling the curriculum: An analysis of alcohol industry-funded school-based youth education programmes
por: van Schalkwyk, May C. I., et al.
Publicado: (2022)